中信证券股份有限公司 关于南京化纤股份有限公司本次交易前12个月内 购买、出售资产情况的核查意见 南京化纤股份有限公司（以下简称"公司"、 "上市公司"）拟通过资产置换、 发行股份及支付现金的方式购买南京工艺装备制造股份有限公司 100%股份，并 募集配套资金（以下简称"本次交易"）。中信证券股份有限公司（以下简称"本 独立财务顾问"）作为上市公司本次交易的独立财务顾问，对公司本次交易前 12 个月内购买、出售资产情况核查如下： 根据《上市公司重大资产重组管理办法》第十四条第一款第（四）项规定： "上市公司在十二个月内连续对同一或者相关资产进行购买、出售的，以其累计 数分别计算相应数额。已按照本办法的规定编制并披露重大资产重组报告书的资 产交易行为，无须纳入累计计算的范围。中国证监会对本办法第十三条第一款规 定的重大资产重组的累计期限和范围另有规定的，从其规定。交易标的资产属于 同一交易方所有或者控制，或者属于相同或者相近的业务范围，或者中国证监会 认定的其他情形下，可以认定为同一或者相关资产。" 本次交易前 12 个月内，上市公司未发生与本次重组相关的购买、出售重大 资产的交易行为，不存在购买、出售与本次交 ...

华泰联合证券有限责任公司 关于不存在《上市公司监管指引第 7 号——上市公司重大资 产重组相关股票异常交易监管》第十二条不得参与上市公司 重大资产重组情形的承诺 南京化纤股份有限公司（以下简称"公司"、 "上市公司"）拟通过资产置换、 华泰联合证券有限责任公司 年 月 日 发行股份及支付现金的方式购买南京工艺装备制造股份有限公司 100%股份，并 募集配套资金（以下简称"本次交易"）。华泰联合证券有限责任公司（以下简称 "本独立财务顾问"）作为上市公司本次交易的独立财务顾问，现根据《上市公 司监管指引第 7 号——上市公司重大资产重组相关股票异常交易监管》第十二条 之规定，就本公司及相关经办人员是否存在不得参与任何上市公司重大资产重组 的情形承诺如下： 本独立财务顾问及本独立财务顾问的经办人员不存在泄露本次交易内幕信 息以及利用本次交易信息进行内幕交易的情形，不存在因涉嫌本次交易相关的内 幕交易被立案调查或者立案侦查的情形，最近 36 个月内不存在因涉嫌与重大资 产重组相关的内幕交易被中国证券监督管理委员会作出行政处罚或者被司法机 关依法追究刑事责任的情形，不存在依据《上市公司监管指引第 7 号——上市公 司 ...

Core Viewpoint - Nanjing Chemical Fiber Co., Ltd. plans to acquire 100% of Nanjing Process Equipment Manufacturing Co., Ltd. through asset swap, issuance of shares, and cash payment, while raising matching funds [1][2] Group 1: Compliance with Regulations - The transaction complies with Article 11 of the Major Asset Restructuring Management Measures, as the board believes it meets the legal and regulatory requirements for external investments [1] - The asset valuation is based on a report from a qualified asset appraisal agency, ensuring fair pricing and protection of the company's and shareholders' rights [1] - The handling of debts and liabilities is legal, and the main assets are not cash or non-operational businesses [1] Group 2: Enhancing Independence - The transaction aligns with Article 43 of the Major Asset Restructuring Management Measures, promoting the company's independence and reducing related party transactions [2] - Effective measures will be implemented to avoid competition within the same industry [2] - The assets involved are clearly defined operational assets, with the ability to complete ownership transfer within the agreed timeframe [2]

Core Viewpoint - The company plans to acquire 100% equity of Jiangsu Langyan Life Science Technology Co., Ltd. through the issuance of shares and convertible bonds, which aligns with relevant regulations and policies [1][2][7]. Compliance with Regulations - The transaction complies with national industrial policies and relevant laws regarding environmental protection, land management, anti-monopoly, foreign investment, and outbound investment [1][2]. - The transaction does not require prior approval from the Ministry of Commerce as it does not meet the concentration declaration standards [2]. - The transaction will not affect the company's compliance with stock listing conditions, as the public shareholding ratio will remain above 25% post-transaction [2][3]. Asset Valuation and Legality - The asset pricing is fair and does not harm the company's or shareholders' legal rights, with an independent evaluation process in place [3][4]. - The ownership of the assets is clear, and there are no legal obstacles to the transfer of ownership [4][5][10]. Business Synergy and Growth Potential - The acquisition is expected to enhance the company's operational capabilities by leveraging its R&D strengths alongside Langyan's production and sales advantages, creating new profit growth points [5][11]. - The transaction will expand the company's business into the pharmaceutical industrial sector, establishing a "CRO + pharmaceutical industry" layout that is anticipated to improve profitability and risk resistance [5][7]. Independence and Governance - The company maintains independence from its controlling shareholders in terms of business, assets, finance, personnel, and institutions, complying with relevant regulations [6][8]. - The company has a sound corporate governance structure, ensuring compliance with laws and regulations post-transaction [6][7]. Financial Health and Compliance - The company has received a standard unqualified audit report for the last fiscal year, indicating no issues with financial reporting [8][9]. - The transaction will reduce related party transactions and avoid competition with the controlling shareholder's other enterprises, enhancing the company's independence [7][8].

证券代码：300121 证券简称：阳谷华泰 公告编号：2025-071 债券代码：123211 债券代码：阳谷转债 山东阳谷华泰化工股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 山东阳谷华泰化工股份有限公司（以下简称 "公司"、"上市公司"或"阳 谷华泰"）拟通过发行股份及支付现金方式购买波米科技有限公司（以下简称"波 米科技"或"标的公司"）100%股权并募集配套资金（以下简称"本次交易"或 "本次重组"）。 根据《上市公司重大资产重组管理办法》《上市公司监管指引第 7 号——上 市公司重大资产重组相关股票异常交易监管》《公开发行证券的公司信息披露内 容与格式准则第 26 号——上市公司重大资产重组》 《监管规则适用指引——上市 类第 1 号》等法律、法规的要求，上市公司对本次交易相关内幕信息知情人买卖 上市公司股票的自查报告进行了核查，具体如下： 一、本次交易的内幕信息知情人买卖股票情况的自查期间 本次交易自查期间为自上市公司首次披露本次重组事项或就本次重组申请 股票停牌（孰早）前六个月至《山东阳谷华泰化工股份有限公司发行股份及支付 现金购 ...

Core Viewpoint - The acquisition of Baode Computer by Huibo Yuntong may face uncertainties, as only a few minority shareholders have expressed intent to transfer their shares, and the ability to secure controlling interest remains to be seen. Additionally, the company's major shareholder is approaching a significant share unlock period, raising questions about the motivations behind restarting the merger and acquisition process. Huibo Yuntong has experienced poor earnings quality since its IPO, with some shareholders frequently reducing their stakes [1][6][11]. Group 1: Acquisition Details - Huibo Yuntong announced plans to issue shares and pay cash to acquire control of Baode Computer, while also raising supporting funds. The transaction is not expected to change the actual controller of the company [1][4]. - The identified transaction counterparties include several minority shareholders, but the largest shareholder, Horgos Baode Venture Capital Co., Ltd., which holds 38.2331% of shares, has not indicated any intention to transfer shares [2][4]. Group 2: Company Performance - Huibo Yuntong's financial performance has shown revenue growth without corresponding profit increases. The net profit margin has declined from 9.63% in 2020 to 6.91% in 2024, with a first-quarter net profit margin of only 0.4% [6][10]. - For the fiscal year 2024, Huibo Yuntong reported total revenue of 1.743 billion yuan, a year-on-year increase of 28.30%, but a net profit of 66 million yuan, down 20.45% year-on-year. The first quarter of 2025 saw revenue of 506 million yuan, a 37.46% increase, but a net profit decline of 72.13% [10][11]. Group 3: Shareholder Actions - In light of the company's declining performance quality, some shareholders have begun to reduce their holdings. For instance, Guizhou Yunli High-tech Industry Investment Partnership reduced its stake by approximately 1.10 million shares, representing 0.99988% of the total share capital [11][12]. - Ningbo Heyitongda Venture Capital Partnership also reduced its holdings by 400,000 shares, accounting for 1% of the total share capital, with a total of 1.549 million shares sold over the past year [11][12].

Core Viewpoint - The report outlines the independent financial advisory role of CITIC Securities in the acquisition of assets by China Energy Conservation and Environmental Protection Group Co., Ltd. through a combination of share issuance and cash payment, along with the associated fundraising and related party transactions [1][2]. Group 1: Transaction Overview - The company plans to acquire 100% equity of Environmental Technology from China Environmental Protection and minority stakes in several subsidiaries from Hebei Construction Investment through share issuance and cash payment [2][3]. - The total assessed value of the acquired assets is approximately 1,075.57 million yuan for Environmental Technology and 40.84 million yuan for the minority stakes [3][4]. Group 2: Payment Structure - The payment for the transaction will be a combination of share issuance and cash, with specific amounts allocated to each party involved [4]. - The company intends to raise up to 300 million yuan through the issuance of shares to no more than 35 specific investors, with the issuance price set at no less than 80% of the average trading price over the previous 20 trading days [4][5]. Group 3: Implementation Status - As of June 2023, the transfer of ownership for the acquired assets has been completed, with Environmental Technology and other subsidiaries officially becoming wholly-owned or majority-owned subsidiaries of the company [6][8]. - The issuance of new shares has been completed, with a total of approximately 2.18 billion shares issued, increasing the total share count to approximately 2.61 billion [9][11]. Group 4: Fundraising and Financial Details - The total amount raised from the share issuance was approximately 2.99 billion yuan, with net proceeds after expenses amounting to about 2.97 billion yuan [11][14]. - The shares issued are subject to a six-month lock-up period, during which they cannot be transferred [13][29]. Group 5: Compliance and Commitments - The independent financial advisor confirms that all necessary approvals and disclosures have been completed in accordance with relevant laws and regulations [15]. - The company and its related parties have made commitments to ensure compliance with regulations and to avoid conflicts of interest in future transactions [26][36].

Group 1 - The core viewpoint of the news is that the China Securities Regulatory Commission (CSRC) is committed to stabilizing and promoting the healthy development of the Chinese stock market through a series of financial policies and regulatory measures [1][5][7] - Since the release of the "Six Merger and Acquisition Guidelines" in September 2024, the number of disclosed restructuring projects in the Shanghai and Shenzhen stock markets has reached nearly 1,400, a year-on-year increase of 40%, with significant asset restructurings exceeding 160, marking a 2.4 times increase [3][4] - The CSRC plans to expedite the release of the revised "Major Asset Restructuring Management Measures for Listed Companies" and related regulatory guidelines to enhance the role of the capital market as the main channel for mergers and acquisitions [4][5] Group 2 - The trend of domestic companies going public overseas is gaining momentum, which is seen as a crucial step in their globalization process, allowing them to access a broader international investor base and enhance their global competitiveness [5][6] - The "A+H" listing strategy is becoming increasingly popular among A-share companies, providing new international opportunities and enhancing the attractiveness of both domestic and international markets [6][9] - The return of quality Chinese concept stocks (Chinext) is expected to positively impact both the Hong Kong and mainland markets, increasing the representation of emerging industries and improving market dynamics [7][8] Group 3 - The return of quality Chinese concept stocks will provide domestic investors with more high-quality investment options, helping to diversify investment risks and improve portfolio returns [8][9] - Hong Kong's role as an international financial center is emphasized, serving as a bridge for Chinese companies' globalization efforts, with the Hong Kong Stock Exchange continuously introducing innovative systems to support this [9]

Core Viewpoint - The China Securities Regulatory Commission (CSRC) is set to introduce multiple policies aimed at enhancing the quality of public funds and supporting technological innovation in the financial market [1][3]. Policy Initiatives - **Policy One**: The CSRC will release an "Action Plan for Promoting High-Quality Development of Public Funds," which emphasizes aligning the interests of public funds with investors. This includes optimizing the fee structure for actively managed equity funds, where underperforming funds will charge lower management fees. Performance metrics such as benchmark comparisons and investor profit/loss will be integrated into the assessment of fund companies and managers, shifting focus from "scale" to "returns" [3]. - **Policy Two**: The CSRC will expedite the release of a revised "Management Measures for Major Asset Restructuring of Listed Companies" and related regulatory guidelines [3]. - **Policy Three**: New measures to deepen reforms in the Sci-Tech Innovation Board and the Growth Enterprise Market will be introduced, enhancing the inclusivity and adaptability of the regulatory framework, particularly in market structure, review mechanisms, and investor protection [3]. - **Policy Four**: There will be a strong push to develop technology innovation bonds, optimizing the issuance registration process and improving credit enhancement support to provide comprehensive financial services for tech enterprises [3]. Support for Technology Innovation Bonds - The People's Bank of China and the CSRC jointly announced measures to support the issuance of technology innovation bonds, aligning with the goals set forth in the 20th National Congress. This initiative aims to broaden financing channels for tech innovation companies and stimulate market vitality [4][5]. - The announcement includes several measures to enrich the product system for technology innovation bonds and improve supporting mechanisms. Key points include: - Encouraging financial institutions and tech companies to issue various types of technology innovation bonds, including corporate bonds and debt financing instruments [5]. - Allowing issuers to flexibly set bond terms, promoting the issuance of long-term bonds to better match the funding needs of the tech sector [5]. - Streamlining bond issuance management and innovating credit rating systems to facilitate financing for technology innovation bonds [5]. - Including technology innovation bonds in the evaluation of financial institutions' performance in technology finance services [5]. - Encouraging local governments to provide interest subsidies and guarantees for these bonds [5].

经核查，本独立财务顾问认为，本次交易相关主体不存在依据《上市公司监 管指引第 7 号——上市公司重大资产重组相关股票异常交易监管》第十二条或 《上海证券交易所上市公司自律监管指引第 6 号——重大资产重组》第三十条规 定不得参与任何上市公司重大资产重组的情形。 特此说明。 （以下无正文） 中国国际金融股份有限公司 关于本次交易相关主体不存在《上市公司监管指引第 7 号—— 上市公司重大资产重组相关股票异常交易监管》第十二条或 《上海证券交易所上市公司自律监管指引第 6 号—— 重大资产重组》第三十条规定的不得参与任何上市公司重大资产 重组情形的核查意见 中国国际金融股份有限公司（以下简称"中金公司"、"独立财务顾问"）接 受希荻微电子集团股份有限公司（以下简称"公司"）委托，担任其发行股份及支 付现金方式购买深圳市诚芯微科技股份有限公司 100%股份并募集配套资金（以 下简称"本次交易"）的独立财务顾问，本独立财务顾问就本次交易相关主体不 存在不得参与任何上市公司重大资产重组情形出具核查意见如下： 截至本核查意见出具之日，本次交易涉及的《上市公司监管指引第 7 号—— 上市公司重大资产重组相关股票异常交易监管 ...